Group One Trading, L.P. Igm Biosciences, Inc. Transaction History

Group One Trading, L.P.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$6.51 - $11.47 $1,953 - $3,441	300 Added 7500.0%	304 $2,000
Q1 2024 May 10, 2024	BUY	$8.68 - $17.36 $34 - $69	4 New	4 $0
Q3 2023 Nov 09, 2023	BUY	$6.66 - $10.64 $1,332 - $2,128	200 New	200 $1,000
Q3 2022 Nov 09, 2022	BUY	$15.42 - $27.01 $11,657 - $20,419	756 New	756 $17,000
Q1 2022 May 12, 2022	SELL	$13.42 - $29.73 $163,361 - $361,903	-12,173 Closed	0 $0
Q4 2021 Feb 11, 2022	BUY	$27.59 - $66.39 $143,550 - $345,427	5,203 Added 74.65%	12,173 $357,000
Q3 2021 Nov 12, 2021	BUY	$65.76 - $90.65 $458,347 - $631,830	6,970 New	6,970 $458,000

20.7M

68K

52.2K

Ticker IGMS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 28,969,000
Market Cap $189M
Description
IGM Biosciences, Inc., a biotechnology company, develops Immunoglobulin M (IgM) antibodies for the treatment of cancer, infectious diseases, and autoimmune and inflammatory diseases. The company's lead product candidate is IGM-2323, a bispecific IgM antibody that is in Phase 2 clinical trials to treat patients with relapsed/refractory B cell Non...

Get notified when there are updates to the investment portfolio of Group One Trading, L.P., based on Form 13F filings with the SEC.

Stay updated on Group One Trading, L.P. with notifications on news.